The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 23 | 70.1x | 20.1x | Below average | |
Growth | 73 | 82.6% | 5.6% | Above average | |
Quality | 54 | -596.6% | 7.6% | Near average | |
Safety | 62 | -0.6x | 0.4x | Near average | |
Capital Return | 25 | — | 2.19% | Below average | |
Momentum | 22 | — | — | Below average | |
Sentiment | 31 | — | — | Below average |
Alnylam Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Alnylam Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Alnylam stock shows stability in the average price target at 445.67 dollars, representing a significant price premium (over 50%) above the current price of 295.63 dollars. Despite the stability of the average, we note a contraction in the number of analysts covering the stock from 14 to 10 analysts over the past week, indicating a concentration of expectations around a price range starting from a minimum of 351 dollars, which remains higher than the current market price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.